AzTrials
AzTrials

Traumatic Brain InjuryTCD TBINCT07107997

Transcranial Doppler in Traumatic Brain Edema

An observational study of Traumatic Brain Injury, run by Alexandria University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to assess the role of transcranial Doppler (TCD) in evaluating brain edema in traumatic brain injury. The main question it aims to answer is: Is TCD equivalent to brain computerized tomography (CT) in evaluating traumatic brain edema? Participants will be examined by both methods at… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Traumatic Brain Injury
How many people
70 participants
Where
1 siteEgypt
Study dates
13 Oct 2024to 13 Jun 2025
How long will I take part?
3 Days
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients admitted to Critical Care Medicine Department in Alexandria University Hospitals

Who may be able to join

  • Patients with brain edema following traumatic brain injury, admitted within 24 hours

Who cannot join

  • Patients presented by out of hospital cardiac arrest or in-hospital cardiac arrest before performing the transcranial Doppler.
  • Pregnant females.
  • Inability to obtain adequate ultrasound window.
  • Temporal bone fracture or brain herniation.
  • Open head injuries or patients in need for surgical intervention

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Alexandria Main University Hospital

    Alexandria, Other (Specify)

Other trials in Egypt

About this study

Official title: Transcranial Doppler Versus Computed Tomography In Evaluation Of Brain Edema In Patients With Traumatic Brain Injury

The goal of this clinical trial is to assess the role of transcranial Doppler (TCD) in evaluating brain edema in traumatic brain injury. The main question it aims to answer is:

Is TCD equivalent to brain computerized tomography (CT) in evaluating traumatic brain edema?

Participants will be examined by both methods at the same time to assess the correlation between them.

Read the detailed description

Computed Tomography (CT) scan of the brain will be done on admission to the ICU and 48-72 hours after starting hyperosmolar therapy. The cerebral oedema will be scored as follows: 0 = no brain oedema, 1 = mild brain oedema, 2 = moderate brain oedema, and 3 = severe brain oedema. Oedema is defined as mild when the ventricles and cisterns are narrow in the CT in the acute stage; moderate, when in addition to the mild form, the sylvian fissure and cortical gyri are not visualized; and severe, when in addition to mild and moderate, the perimesencephalic cisterns can not be visualized.

Transcranial doppler ultrasonography will be performed immediately after CT scan then after 48-72 hours of starting hyperosmolar therapy according to the following protocol:

  • The examination will be done using phased array probe using (Versana active, general electric medical systems china Co.Ltd) ultrasound (US) device.
  • Standing behind the head of the patient, the 2 Mega Hertz (MHz) transducer will be placed over the temporal area just above the zygomatic arch and in front of the tragus of the ear and oriented slightly upward and anteriorly.
  • A red color signal (i.e. flow towards the probe) at a depth between 40-65 mm will represent the flow in the ipsilateral middle cerebral artery.
  • The angle and position of insonation will be adjusted to provide the highest quality Doppler signal.
  • By applying pulsed wave on the insonated segment, Peak Systolic Velocity (PSV) and End Diastolic Velocity (EDV) will be measured and recorded on US machine.
  • Mean flow velocity (MFV) will be calculated using the formula: (PSV+(EDVx 2))/3.
  • Pulsatility index (PI) is calculated using the formula: (PSV-EDV)/ MFV.
  • Intracranial pressure (ICP) will be calculated as follows:
  • CPP is calculated as: MAP*(EDV /MFV) + 14. where MAP is the mean arterial blood pressure.
  • ICP is then calculated as: MAP - CPP.

All patients in the study will be managed using the same management principles of traumatic brain injury with raised intracranial pressure such as:

  • Hyperosmolar therapy either with 20% mannitol or 3% hypertonic saline.
  • Control fever and seizures.
  • Elevate head of bed 30-45.
  • Adequate analgesia and sedation.
  • Maintain systolic blood pressure > 90 mmHg.
  • Maintain partial pressure of carbon dioxide (PaCo2) between 35-38 mmHg.
  • Maintain partial pressure of oxygen (Pao2) between 80-120 mmHg.
  • Avoid hyponatremia.
  • Maintain Hb > 9 g/dL.
Keywords
Transcranial Doppler, Traumatic brain injury
Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07107997
Study groupRoleWhat they receive
Traumatic brain injury patientsTraumatic brain injury patients, with brain edema

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. correlation between transcranial Doppler and brain CT in assessment of brain edema

    Measured: 72 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2025
  2. Study start13 Oct 2024
  3. Primary completion13 Apr 2025
  4. Study completion13 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
70 participants (actual)
Target duration
3 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07107997
Sponsor's protocol ID
0108653
Acronym
TCD TBI
Status last verified
Jul 2025
First submitted
31 Jul 2025
Last updated
12 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Traumatic Brain Injury, run by Alexandria University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

correlation between transcranial Doppler and brain CT in assessment of brain edema (time frame: 72 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2025; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in